Replies to post #2146 on Teva Pharmaceutical Industries Ltd (TEVA)

[DewDiligence]

Generic Copaxone: [The FDA] have plenty of time until Feb, 2011 when the 30-month stay expires… No way the FDA will treat generic Copaxone other than a biologic drug.

Your first sentence is clearly true; your second sentence is Teva propaganda.

If the FDA were going to treat Copaxone as a biologic, they would have not accepted Sandoz’s ANDA for review.